A New Era for Cancer Immunotherapy Based on the Genes that Encode Cancer Antigens
Abstract
No abstract availableThis publication has 73 references indexed in Scilit:
- Overlapping peptides of melanocyte differentiation antigen melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1International Journal of Cancer, 1998
- A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck CarcinomaJournal of Experimental Medicine, 1997
- Cancer Cell CyclesScience, 1996
- Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the geneMAGE-3International Journal of Cancer, 1996
- Recognition of out‐of‐frame major histocompatibility complex class I‐restricted epitopes in vivoEuropean Journal of Immunology, 1996
- Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA moleculesHuman Immunology, 1996
- Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selectionEuropean Journal of Immunology, 1995
- Minimal requirements for peptide mediated activation of CD8+ CTLMolecular Immunology, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991